THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS
NOW AVAILABLE FOR POCKET PC

NEW ROCHELLE, NY — June 28, 2007
The Medical Letter is pleased to announce the release of its flagship publication - The Medical Letter on Drugs and Therapeutics - for Pocket PC, powered by USBMIS.

"The Medical Letter Inc. is delighted to have its content on the USBMIS platform – a leading provider of medical content to PDA users." said Mark Abramowicz, MD, Editor of The Medical Letter. "The Medical Letter’s mission of distributing unbiased, evidence-based drug information will benefit from the extensive market penetration and excellent reputation of USBMIS products."

USBMIS, a respected software developer for the medical industry, plans to release a BlackBerry version of this valuable product in the near future, along with other top medical references from The Medical Letter.

For more information about The Medical Letter on Drugs and Therapeutics Pocket PC edition, please visit http://www.usbmis.com/mldt/.

About The Medical Letter
The Medical Letter Inc., a nonprofit organization founded in 1958, offers health care professionals objective, independent analyses of both prescription and over-the-counter drugs. In addition to its newsletters, The Medical Letter on Drugs and Therapeutics and Treatment Guidelines from The Medical Letter, it also publishes handbooks and software on topics such as adverse drug interactions and antimicrobial therapy. The Medical Letter, Inc. is supported entirely by subscriber fees and is based in New Rochelle, NY. For more information about The Medical Letter call (800) 211-2769 or visit their Web site at www.medicalletter.org.